The PDGFRA gene gives cells instructions for a protein on the cell surface that receives growth signals and helps control how certain cells grow, survive, and mature. When this gene does not work normally, those signals can become too weak or too strong, which may disrupt normal development or let cells grow out of control. This gene plays an important role in tissues such as connective tissue and the digestive tract. Many people first hear about the PDGFRA gene during cancer testing, because certain variants are linked to some gastrointestinal stromal tumors and can help guide treatment decisions.
What is a gene?
Genes are sections of DNA that store instructions your cells use to make molecules or direct processes throughout the body. Some carry the code for proteins, which are the parts of cells that do much of the work. Others mainly regulate when specific processes happen, where they take place, and how strongly they operate. As a group, genes influence how the body develops and functions, and they can shape your response to food, stress, or medications. More on this topic is available in the LearnHub.
Overview
PDGFRAGene function
What if the gene works
The PDGFRA gene helps cells receive growth signals that guide when to grow, divide, and mature. It is especially important in connective tissue development and in repairing tissues after injury.
Risk
What if the gene does not work
Changes in the PDGFRA gene are best known for driving certain tumors, especially gastrointestinal stromal tumors, and some blood cancers with high eosinophils. Milder and more severe variants can influence which condition develops and how early or strongly it appears.
Treatment
What does that mean for your treatment
Treatment relevance is established for certain activating variants in the PDGFRA gene. Many PDGFRA driven tumors can respond to imatinib, but the PDGFRA p.Asp842Val variant usually does not, so avapritinib is commonly used instead. A separate PDGFRA specific treatment approach for loss of function variants is not currently established.
Conditions associated with PDGFRA
Gene function
What if the gene works
Many of your body’s support tissues rely on the PDGFRA gene to sense nearby growth signals. It helps certain cells know when to grow, move, and organize themselves as tissues form and renew. Understanding how the PDGFRA gene works in the body helps explain how connective tissues stay structured over time.
The PDGFRA gene makes a receptor on the cell surface that detects growth signals sent by nearby cells. This lets cells read their surroundings and begin an organized response.
When this receptor is switched on, it passes messages that support normal cell growth and division. This is especially important for cells that build and maintain connective tissues.
PDGFRA signaling helps some cells move to the right place during development and routine tissue upkeep. That controlled movement helps tissues take shape and stay organized.
This gene is active in many cells that form the body’s support framework, including connective tissue cells. It helps guide how these cells mature and work together as tissues develop.
What is a variant?
A genetic variant is a minor alteration in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can affect how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the PDGFRA gene change how strongly its cell surface protein sends growth signals, which is central to how PDGFRA gene variants affect cell signaling. In many cancers, activating variants keep the protein stuck in an “on” state, so signaling continues without the usual trigger. Milder changes may only partly raise activity, while more severe variants can make signaling more constant and may influence how early or strongly related features appear. Other disruptive variants can lower protein stability or keep it from reaching the cell surface.
How variants are linked to conditions
Variants in the PDGFRA gene are most strongly linked to gastrointestinal stromal tumors, so PDGFRA gene variants and GIST are the best established association. Some inherited PDGFRA variants can cause a familial GIST syndrome, while acquired variants are found only in the tumor itself. Other well-established PDGFRA-related conditions include inflammatory fibroid polyps and certain blood cancers with eosinophilia when PDGFRA is rearranged.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology, and they are widespread in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that clearly increase or reduce health risk related to the PDGFRA gene. Risk usually depends more on the exact gene change and whether it is inherited or happens only in certain cells.
Inheritance of PDGFRA variants
For families asking how PDGFRA gene variants are inherited, the best-established inherited pattern is autosomal dominant for rare familial PDGFRA-related gastrointestinal stromal tumor syndromes. This means a parent carrying a disease-causing variant in the PDGFRA gene can pass it to a child of any sex, and each pregnancy has a 50% chance of inheriting that variant. Sons and daughters are affected equally because the PDGFRA gene is on chromosome 4, which is not a sex chromosome.
What does my PDGFRA result mean for my family?
For inherited PDGFRA changes linked to familial gastrointestinal stromal tumors, close relatives can matter too. A parent, brother, sister, or child may also carry the same change, so the result can have implications across generations. In these families, each child of someone with the variant has a 50% chance of inheriting it.
Genetic information
Genetic testing
How you find out about variants
For the PDGFRA gene, genetic testing is how you find out about variants, usually by reading DNA from a blood, saliva, or tumor sample with sequencing. The result may identify an inherited or acquired variant in the PDGFRA gene and can help clarify a diagnosis, especially in certain tumors, alongside other clinical findings.
When should I consider getting a genetic test?
Genetic testing for PDGFRA may be worth discussing if you have a gastrointestinal stromal tumor, often called GIST, because changes in this gene can help confirm the tumor type and guide treatment. Inherited testing may also be considered if GIST runs in your family or if several relatives have had similar stomach or bowel tumors.
A genetic result is only one part of your health story
Genetic results can be informative, but how much clarity they provide varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Part of the reason is that inherited differences can change how the body breaks down, transports, or responds to a drug. These differences are common and can influence both how well a medicine works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics studies how genetic differences affect the way a person responds to medications. It examines links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed and more individualized treatment decisions. You can learn more about this topic in the LearnHub.
Drugs influenced by the PDGFRA gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in routine medication response, so general questions about medicines, side effects, or treatment changes are best discussed with your doctor. In cancer care, PDGFRA changes in a tumor can help doctors understand whether certain targeted treatments are more or less likely to work. This matters most for people living with a PDGFRA-related tumor who are starting or changing treatment.
History
The PDGFRA gene entered medical research as scientists mapped a family of growth signal genes in the 1980s. In recent decades, awareness of this gene’s role has grown. Early cancer studies brought it into focus, and researchers later connected PDGFRA variants to some gastrointestinal stromal tumors and a small group of blood conditions with high eosinophil counts. These findings helped reshape how certain tumors were classified, moving care away from appearance alone and toward gene based diagnosis. From these first observations, research expanded steadily. Today, the history of the PDGFRA gene is closely tied to the rise of precision medicine, where treatment decisions may be guided by the genetic change found in a tumor.